微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
NeuroMetrix (NASDAQ:NURO) +65%
Reneo Pharmaceuticals (NASDAQ:RPHM) +25%
Neoleukin Therapeutics (NASDAQ:NLTX) +23%
InspireMD (NASDAQ:NSPR) +16%
Chembio Diagnostics (N...查看全文
$InspireMD(NSPR)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-21-009079 Act: 34 Size: 54 KB 网页链接
$InspireMD(NSPR)$ 8-K Current report, items 5.07, 8.01, and 9.01 Accession Number: 0001493152-21-008733 Act: 34 Size: 71 KB 网页链接
$InspireMD(NSPR)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001493152-21-007970 Act: 33 Size: 344 KB 网页链接
$InspireMD(NSPR)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001493152-21-006481 Act: 34 Size: 48 KB 网页链接
$InspireMD(NSPR)$ 8-K Current report, item 8.01 Accession Number: 0001493152-21-006205 Act: 34 Size: 31 KB 网页链接
$InspireMD(NSPR)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-21-005716 Act: 34 Size: 155 KB 网页链接
$InspireMD(NSPR)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001493152-21-005661 Act: 34 Size: 45 KB 网页链接
$InspireMD(NSPR)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001493152-21-005564 Act: 34 Size: 6 MB 网页链接
$InspireMD(NSPR)$ DEF 14A Other definitive proxy statements Accession Number: 0001493152-21-003331 Act: 34 Size: 1 MB 网页链接
$InspireMD(NSPR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-21-003204 Size: 8 KB 网页链接